Pulsar Helium Plc (AIM:LSR) delivered an upbeat investor update highlighting strong progress at its flagship Topaz helium project in Minnesota, USA, where concentrations of up to 14.5% helium rank among the highest recorded in North America. Management outlined a clear roadmap to advance Topaz towards development-ready status by mid-2026, supported by recent flow testing that tripled natural rates and achieved up to 1.3 million cubic feet per day under compression. Backed by a recent capital raise, Pulsar plans to drill up to 10 additional wells this year to expand its resource base, building on an independently assessed 0.4 billion cubic feet recoverable helium resource with a 65% chance of commerciality. The company is working with Chart Industries on plant design for potential helium and CO₂ co-production, ensuring robust development and production planning. Management emphasised the strategic value of helium as a critical, high-value commodity used in semiconductors, MRI scanners, and aerospace, with global demand expected to double by 2035. With supportive Minnesota legislation, proximity to key US markets, and additional early-stage assets in Greenland, Pulsar aims to establish itself as a leading primary helium producer delivering supply flexibility to a structurally constrained market. Investors were reassured of management’s significant shareholding, alignment of interests, and the potential for meaningful production from one of the world’s highest-grade helium discoveries.

Cambridge Cognition Holdings Plc (AIM:COG) delivered an investor update highlighting progress on its growth strategy and platform leadership in CNS clinical trials. H1 2025 new sales orders more than doubled to £6.9m (H1 2024: £3.3m), driving the order book to £16.4m at 30 June and underpinning revenue visibility into 2026. Despite lower revenue from a weaker opening order book, the streamlined cost base resulted in an adjusted EBITDA loss of only £0.4m, with deferred revenue rising to £5.7m, supporting future cash conversion. The Group strengthened liquidity with a ~£1m fundraise at a premium and remains on track to repay its £1.5m debt facility by September next year. Commercial momentum is anchored by tier-one pharma (c.48% of the order book) and a diversified study mix across Phases 1–3. The company’s modular platform—digital and voice cognitive assessments, eCOA, and AI-powered data quality tools (including AQuA and speaker identification)—is embedded in global trials, with regulatory engagement progressing (LOI to the FDA for a schizophrenia co-primary digital endpoint). Pipeline and order intake remain strong, with management targeting sustained profitability through 2025–2026. Expansion opportunities in healthcare and consumer wellness aim to create scalable, recurring revenue streams. Keywords: interim results, investor update, company performance, financial results, order book, pipeline, EBITDA, margins, revenue, growth strategy, digital biomarkers, eCOA, CNS trials.

CT Private Equity Trust PLC (LSE: CTPE) delivered its H1 2025 investor update, reporting a 2.5% decline in NAV year-to-date, reflecting quieter private equity markets, currency movements, and slower realisations. Despite this, the portfolio remains resilient, underpinned by strong long-term performance, with NAV total return significantly outpacing broader equity indices over 10 years. Realisations of £27.1m were lower versus £54m in H1 2024, as global macroeconomic uncertainty and US tariff policy delayed transactions, though several profitable exits were achieved, including Dotmatics (8.4x MOIC, 80% IRR) and Inflexion-backed assets generating strong multiples. New investments included Finnish IT services firm Friendy, Spanish mid-market buyout fund CEA, and Castle Mite Impact Partners, strengthening exposure to technology, healthcare, and sustainability-led growth. The trust maintained its quarterly dividend at 7.01p, reaffirming its upwards-only dividend policy, which has supported over a decade of consistent growth. Portfolio diversification remains a key strength, with co-investments now 40% of NAV and a target of 50%. Gearing is modest and strategically deployed, with £100m drawn against a robust balance sheet and undrawn commitments of £178m. Management reiterated confidence in the long-term growth strategy, highlighting strong underlying portfolio EBITDA growth of c.20%, resilient margins, and a pipeline of attractive co-investment and fund opportunities across Europe and the UK, where CTPE holds 41% exposure. While private equity realisations have slowed sector-wide, the trust continues to achieve exits at premiums to carrying value, supporting NAV resilience. Looking ahead, management expects deal flow and realisations to accelerate in H2, underpinned by disciplined capital allocation, attractive valuation entry points, and a focus on secular growth sectors such as software, healthcare, and industrial technology. With its diversified portfolio, disciplined gearing, and proven long-term performance record, CT Private Equity Trust remains well-positioned to deliver sustainable NAV and dividend growth for shareholders.

Alumasc Group Plc (AIM:ALU) delivered record FY25 financial results, outperforming the UK construction sector despite housing market headwinds. Revenue rose 13% to £113.4m, with underlying profit before tax up 9% to £14.2m, driven by strong organic growth and the successful integration of ARP. All three divisions—Water Management, Building Envelope, and Housebuilding Products—achieved record performances, supported by international expansion across Latin America, Europe, and the Middle East. Operating margins were 13.7%, with a clear pathway to the 15-20% target through efficiency initiatives, synergies, and product innovation. Cash conversion remained robust at 106%, leverage was low at 0.35x, and the full-year dividend increased 3% to 11.1%, underlining the Group’s commitment to shareholder returns. Alumasc continues to advance its sustainability agenda, cutting greenhouse gas emissions by 76% since 2018 and maintaining over 80% of its portfolio in environmentally aligned building solutions. With a strong balance sheet, capacity for selective acquisitions, and further self-help initiatives, the Group is well positioned to capture growth from regulatory drivers such as decarbonisation, urban water management, and building safety. Management expects continued progress in FY26, with margin improvement, international growth, and new product launches reinforcing Alumasc’s track record of resilience, strategic delivery, and value creation.

Macfarlane Group PLC (LSE: MACF), the UK’s leading specialist in protective packaging, reported its H1 2025 results with revenue up 13.1% to £153.6m, driven by acquisitions including Petrivi and Polyformes, though organic sales declined 1% due to price deflation and weaker demand. Adjusted operating profit fell 22% to £9.8m as gross margins contracted from 39.7% to 37.8% and operating costs rose with higher labour, property and NI charges. Distribution, accounting for 75% of Group sales, saw flat volumes and pricing pressure amid intense competition, though margins have begun to stabilise in H2. Manufacturing delivered solid growth, boosted by recent acquisitions, with synergies building across the Group. Net debt increased to £15.2m (Dec 2024: £1.9m) reflecting acquisitions, capex, dividend payments and the £4m share buyback programme, while the pension scheme remains in surplus and on track for buy-in. The Board maintained the interim dividend at 0.96p, with cover of 2.4x. Management expects a stronger H2, supported by seasonal uplift, margin recovery, new business wins, tighter cost controls, and benefits from the East Midlands consolidation. The Group continues to prioritise capital discipline, margin improvement, cash generation and shareholder returns, while maintaining a strong acquisition pipeline for 2026 and beyond. With robust customer satisfaction (NPS 61), a clear focus on sustainability and regulatory compliance (EPR), and ongoing European expansion, Macfarlane is confident of delivering full-year results in line with market expectations and positioning for a return to its medium-term 10% operating margin target.

Cleantech Lithium PLC (AIM: CTL), the Chile-focused sustainable lithium developer, provided an investor update following its recent £4.7m fundraising, which received strong institutional and retail support. Proceeds will fund the acquisition of additional licences at Laguna Verde, increasing coverage of the government-designated polygon to 97.5%, a key step towards admission into Chile’s streamlined licensing process. The Government’s indigenous consultation, due to conclude by October 2025, is expected to pave the way for Cleantech to reapply and enter direct negotiations on a Special Lithium Operating Contract (CEOL) ahead of March 2026. Management reiterated confidence that the strengthened land position significantly de-risks the application. Lithium market sentiment is improving, with demand from EVs and energy storage supporting long-term pricing despite near-term volatility. Cleantech’s preliminary feasibility study (PFS), already completed at a cost of $4m, will be updated to reflect the expanded licence area and released once the company is admitted to the fast-track process. This will lead into a definitive feasibility study (DFS) and environmental impact assessment (EIA), alongside negotiations with strategic partners for funding and potential offtake agreements. With high-grade 99.9% battery-quality lithium already produced from pilot-scale work and a robust resource base of 1.6Mt LCE, the project offers significant long-term value potential. The fundraising provides a 12-month cash runway, enabling progress without further equity raises. Management confirmed strong institutional backing and a supportive retail base, highlighting confidence in Cleantech Lithium’s growth strategy and its role in supplying the clean energy transition.

Team Internet Group PLC (AIM:TIG) delivered its interim results for the six months ended 30 June 2025, reporting performance in line with revised expectations set earlier in the year. The Group, operating across Domains, Comparison, and Search, generated resilient earnings despite sector challenges. In Domains, revenue reached $104m with EBITDA up 30% to $10.7m, driven by margin resilience, cost efficiencies, and value-added growth. The Comparison segment produced $28m in revenue, maintaining strong conversion rates while accelerating international expansion into the UK and US. Search remained impacted by Google’s transition from AdSense for Domains to AdSense for Search on Content, resulting in revenue pressure; however, traffic volumes rose to over 7bn visits, underpinning confidence in long-term recovery. Group net debt reduced to $93.3m, supported by robust cash generation and a 109% operating profit-to-cash conversion. Adjusted EBITDA highlighted underlying profitability, while restructuring costs of $4.7m are expected to yield future savings. Management anticipates stronger H2 performance, underpinned by seasonal demand, cost reductions, and growing contributions from international Comparison markets. Strategic priorities remain focused on sustainable EBITDA growth, margin enhancement, and diversification across business lines. Despite investor frustration over share price declines, management reiterated confidence in its strategy, market position, and ability to deliver long-term shareholder value through disciplined execution, improved capital allocation, and continued debt reduction.

Carclo PLC delivered a strong set of full-year 2025 results, marking a successful turnaround and positioning the Group for sustainable long-term growth. Revenue of £121.2m reflected portfolio optimisation, with exits from non-core US operations offset by 20% growth in the Specialty division and 4.5% like-for-like growth in Manufacturing Solutions. Underlying EBITDA increased 12% to over £14m, with margins expanding from 11% to 13% through a disciplined focus on margin over volume, operational efficiency, and a shift to higher-value programmes. Operating profit exceeded £7m, while return on sales reached 8.1% and return on capital employed surged to 24.4%. Net debt fell 40% to £19.2m, supported by three consecutive years of >100% cash conversion. The pension scheme deficit reduced significantly with a clear recovery plan agreed. Strategic priorities remain financial resilience, operational excellence, expansion, and innovation, supported by a leaner manufacturing footprint and strong customer demand across life sciences, aerospace, and precision components. Management highlighted confidence in sustaining double-digit margins, scaling in high-growth markets such as drug delivery systems and in-vitro diagnostics, and leveraging a global factory footprint designed to mitigate geopolitical risks. While dividends remain restricted in the near term, Carclo emphasised reinvestment for growth and shareholder value creation. Overall, FY25 results underline Carclo’s transformation into a safer, more efficient, and more profitable business, with strong momentum into FY26.

PPHE Hotel Group (LSE: PPH), the international hospitality real estate and management company, reported a resilient H1 2025 performance, delivering revenue growth and strong strategic progress despite ongoing macroeconomic and geopolitical pressures. Reported revenue rose 4.7% to £199.9m, with like-for-like revenue up 1.3% supported by higher occupancy levels, which increased 180bps to 72.4%. RevPAR grew 1.4% to £109.3, though EBITDA declined 5.7% to £45.5m due to wage inflation and the phased opening of new hotels. The Group continued its investment cycle, launching the Art’otel Rome Piazza Lucina and completing further phases of the flagship art’otel London Hoxton, including a new destination restaurant and office space. PPHE also invested £17.5m in its first Radisson Red select service hotel in the City of London and increased its stake in Arena Hospitality Group to 65.5%. The portfolio, valued at £2.2bn, is concentrated in London and Amsterdam, with expansion opportunities across Europe. Management reiterated that five new hotels across five capital cities are expected to deliver at least £25m of incremental EBITDA upon stabilisation, with strong momentum in Rome and Hoxton positioning the Group for long-term growth. Balance sheet strength remains a key focus, with conservative 34.5% LTV and fixed-rate debt at an average 3.8% cost. The Board declared an interim dividend of 17p per share, in line with last year, reflecting confidence in free cash flow generation. Looking ahead, PPHE will focus on stabilising new openings, rolling out select service brands, and leveraging technology and automation to protect margins while navigating cost inflation and regulatory changes. The Group remains confident in delivering progressive dividends, growth in EBITDA, and long-term shareholder value creation.